St. Louis, MO (PRWEB) February 05, 2015
Attorneys representing clients nationwide in Xarelto lawsuits that have been consolidated at a multidistrict litigation* announce the MDL is moving forward routinely and new claims are still being accepted. “Many people assume that once the MDL procedure moves forward, it is too late to join. However, our attorneys would like to assure the public there is still a window of opportunity in this particular litigation,” said Jim Onder. The Onder Law Firm provides no-cost, no-obligation Xarelto lawsuit case review for individuals and the family members of individuals who have suffered from internal bleeding or hemorrhagic stroke and have a history of taking Xarelto.
During January 2015, Pretrial Orders #2 and #3 were issued. Both official court documents, the Pretrial Orders establish routine elements in the early process of a multidistrict litigation. Coordinating the counsel is a significant task when the number of plaintiffs swells; as of January 15, 2015, there were 86 Xarelto lawsuits included in the litigation in Louisiana, according to a pending MDL list available from the JPML.** The Pretrial Orders establish mutual understanding regarding the procedures that will take place as the litigation moves forward; Orders 2 and 3 specifically establish one or more individuals as Plaintiffs’ Liaison Counsel (Gerald E. Meunier and Leonard A. Davis) and Defendants’ Liaison Counsel (James B. Irwin), according to the respective court documents.
Xarelto, or rivaroxaban, is an oral anticoagulant or blood thinner commonly prescribed to patients who suffer from a heart condition known as atrial fibrillation and patients recovering from hip or knee replacement surgery, according to court documents. Xarelto lawsuits allege that Xarelto puts patients at risk for life-threatening internal bleeding and hemorrhagic stroke, and further asserts that patients were not adequately warned of these risks. In consolidating the Xarelto lawsuits, the Judicial Panel on Multidistrict Litigation named the following as the commonalities across all the cases: “the adequacy of Xarelto’s warning label with respect to the risk of severe bleeding and other injuries, the results of certain clinical studies, and the alleged need for blood monitoring”, as written in the transfer order, a court document.
Attorneys handling national Xarelto lawsuits for the Onder Law Firm are now accepting claims from persons and the family members of persons who sustained severe internal bleeding or hemorrhagic stroke while taking the oral blood thinner Xarelto. Lawyers are investigating these inquiries for possible inclusion in the Xarelto lawsuit MDL. The Onder Law Firm is recognized or its achievements in product and consumer safety litigation, with a strong track record of winning meaningful settlements for clients. The firm is nationally-renowned for its work on window blind strangulation, and has notable expertise in fighting on behalf of individuals against powerful corporations. Individuals and the family members of individuals who have suffered from internal bleeding and have taken Xarelto are eligible for a no-cost, no-obligation Xarelto lawsuit case review, and may contact the firm through its Xarelto Contingency Lawsuit website where the firm provides information on bleeding warnings and Xarelto lawsuit news.
The Onder Law Firm also welcomes Xarelto lawsuit inquiries from other law firms, either to handle these inquiries or work as co-counsel.
About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O’Leary & Peterson has represented clients throughout the United States, and other firms throughout the nation often seek its experience and expertise on complex litigation. It is a recognized leader in products liability cases such as window blind cord strangulation and pharmaceutical litigation. The Onder Law Firm’s Xarelto attorneys provide information to the public at http://www.XareltoContingencyLawsuit.com.
*In Re: Xarelto Products Liability Litigation, MDL No. 2592